STONEHAM, MA, November 18, 2022 /24-7PressRelease/ -- Dr. Xiaoping Zhang has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Having amassed over two decades of experience working for several pharma and biotechnology companies, Dr. Zhang is a renowned clinical pharmacologist, researcher, and educator whose expertise includes the planning and execution of clinical pharmacology and clinical development strategy for drug development programs. In 2019, she established XP Pharma Consulting LLC in Stoneham, Massachusetts, a go-to company that provides services in the design and implementation of clinical pharmacology-guided drug development strategies across various therapeutic areas, from early to late development and through registration. XP Pharma Consulting specialized in using pharmacokinetics (PK), pharmacodynamics (PD), and PK/PD modeling and simulation techniques to advance the understanding of drug properties, enhancing informed decision-making by the client at each stage of drug development.
Throughout the course of her career, Dr. Zhang has conducted extensive research in her field, including more than 80 international and domestic clinical trials. Notably, she was also the clinical pharmacologist involved in the approval of first approval RNAi therapeutics ONPATTRO® (patisiran) that treats the polyneuropathy caused by an illness called hereditary transthyretin-mediated amyloidosis. Additionally, Dr. Zhang has also secured nine patents in the field of clinical pharmacology, and has contributed to the authoring of more than 70 scholarly articles. Looking toward the future, she aims to become recognized as a leader in clinical pharmacology, PK, PD and PK/PD modeling in various therapeutic areas of medicine.
Dr. Zhang held academic roles at her alma maters – Shanxi University and the University of Witten-Herdecke in Germany. She also held positions at the University of Erlangen-Nuremberg in Germany and University of Kansas in Lawrence and Texas Tech University in the USA. Furthermore, she garnered two decades of proficiency in the field with Hoffmann-La Roche Inc. as a senior clinical director and translational medicine expert from 2001 to 2012. Likewise, she served at Kyowa-Hakko Kirin Pharma Inc. as a clinical director and development team leader, Alexion Pharmaceuticals Inc. as a director of clinical pharmacology, Alnylan Pharmaceuticals Inc. as a senior director of clinical pharmacology and pharmacometrics, and Nuventra Pharma Sciences as a senior consultant of clinical pharmacology and pharmacometrics.
Dr. Zhang received a Bachelor of Science in 1983 and a Master of Science in pharmaceutical science and molecular modeling in 1988 at Shanxi University in China, followed by a Doctor of Philosophy in clinical pharmacokinetics in 1994 at the University of Witte-Herdecke in Germany. Dr. Zhang later returned to China, where she completed a Doctor of Clinical Medicine at Shanxi Medical University in 2019.
Affiliated with several industry-related organizations in support of her career, Dr. Zhang is presently active with the American Society for Clinical Pharmacology and Therapeutics, the American Association of Pharmaceutical Scientists, the International Society of Pharmacometrics, the American Society of Clinical Oncology, and the American Society of Bone and Mineral Research.
In light of her achievements, Dr. Zhang received two Shooting Star Awards for the successful launch of ONPATTRO® (patisiran) in 2019, an Outstanding Scientific Contribution Award for her presentation at the 21st Sino-American Pharmaceutical Professionals Association Scientific Symposium for the Next Generation of Gene and Cell Therapy in 2018, a Steller Supernova Award for Passion for Excellence from Alnylam Pharmaceuticals Inc. in 2017 and, among other accolades, several Presidential Awards from various organizations for her research.
About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #